GlassScriptPhysician profile
Jacob Dominik
NPI 1629233861
$215,603.20
in general payments reported to CMS, 2019-2025
11 companies · $112K in 2025
The $112K reported for 2025 was more than what 98% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $150 · 2021: $452 · 2022: $2,004 · 2023: $52K · 2024: $49K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $138K · Travel and Lodging: $33K · Consulting Fee: $20K · Honoraria: $12K · Food and Beverage: $8,978 · Education: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $137,900.00 |
| Travel and Lodging | $32,943.73 |
| Consulting Fee | $20,374.50 |
| Honoraria | $12,300.00 |
| Food and Beverage | $8,978.25 |
| Education | $350.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $143,853.96 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $64,800.97 | 2023-2025 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $4,329.24 | 2025 | |
| Harmony Biosciences LLC | $1,376.79 | 2020-2025 | Wakix |
| Noctrix Health, INC. | $577.83 | 2025 | Nidra |
| Axsome Therapeutics, INC. | $400.09 | 2023-2025 | Sunosi |
| Fisher & Paykel Healthcare INC | $97.01 | 2022-2025 | Fisher & Paykel Healthcare |
| Inspire Medical Systems, INC. | $76.58 | 2023 | Inspire |
| Idorsia Pharmaceuticals US INC | $39.67 | 2023-2024 | Quviviq |
| Lilly USA, LLC | $29.44 | 2025 | Zepbound |
| Novo Nordisk INC | $21.62 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Dominik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.